Series A financings for biopharma, medtech, and diagnostics start-ups totaled $627.5 million in the first half of 2014. That’s 8% less than the same period last year, when the half-year figure stood at $684.7 million, en route to a year-end total of $1.4 billion. The number of Series A rounds was down more dramatically: just 34 Series A rounds closed in H1 2014 compared with 53 deals in H1 2013.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Scrip for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?